JohnMichaelWallmarkMD

Oncology • Bethesda, MD

Physician

Join to view full profile

Dr. Wallmark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wallmark's full profile

Already have an account?

Office
6420 Rockledge Dr
Ste 4200
Bethesda, MD 20817
Phone+1 301-424-6231

Fax+1 301-294-4648
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1995 - 1998
University of North Carolina HospitalsResidency, Internal Medicine, 1992 - 1995
Drexel University College of MedicineClass of 1992

Certifications & Licensure

MD State Medical License 1998 - 2025
FL State Medical License 2018 - 2020
PA State Medical License 1995 - 1998
NC State Medical License 1992 - 1995
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Clinical Trials

Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Start of enrollment: 2013 Dec 13
Active, not recruiting
Phase 3
Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
Terminated
Phase 2

Publications & Presentations

PubMed

123 citations
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.
Cohen, R. B., Cohen, R. B., Delord, J. P., Delord, J. P., Doi, T., Doi, T., Piha-Paul, S. A., Piha-Paul, S. A., Liu, S. V., Liu, S. V., Gilbert, J., Gilbert, J., Algaz...> ;American journal of clinical oncology. 2018 Feb 21
184 citations
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
Bert H. O'Neil, John M. Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina Anne Piha-Paul, Mark N. Stein, Albiruni Ryan Abd...> ;Plos One. 2017 Dec 28
Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.
Nieves, D. S., Bondi, E. E., Wallmark, J., Raps, E. C., Seykora, J. T.> ;Cutis. 2000 Feb
Tamoxifen's impact on the management of breast cancer: the oncologist's perspective.
Glick, J. H., Aviles, V. M., Wallmark, J.> ;Oncology (Williston Park). 1997 Feb
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Adventist Healthcare Shady Grove Medical CenterRockville, Maryland
Suburban HospitalBethesda, Maryland
Holy Cross HospitalSilver Spring, Maryland